Transportability Methods to Extend Inferences from Contemporary Type 2 Diabetes Clinical Trials to Veterans
Va Eastern Colorado Health Care System, Aurora CO
Investigators
Abstract
7\SH GLDEHWHV PHOOLWXV 7' LV D FRPPRQ FKURQLF GLVHDVH DVVRFLDWHG ZLWK PRUELG DQG FRVWO\ FRPSOLFDWLRQV LQFOXGLQJ FDUGLRYDVFXODU GLVHDVH DQG FKURQLF NLGQH\ GLVHDVH ± WRJHWKHU UHIHUUHG WR DV FDUGLRUHQDO FRPSOLFDWLRQV 1HZ PHGLFDWLRQ FODVVHV ± JOXFDJRQOLNH SHSWLGH UHFHSWRU DJRQLVWV */35$ DQG VRGLXPJOXFRVH FRWUDQVSRUWHU LQKLELWRUV 6*/7L ±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± LQ WKLV FDVH 9HWHUDQV ZLWK 7' ZKR PHHW 5&7 LQFOXVLRQH[FOXVLRQ FULWHULD 3ULRU ZRUN IURP WKH LQYHVWLJDWRU WHDP KDV GHPRQVWUDWHG WKH YDOLGLW\ RI WUDQVSRUWDELOLW\ PHWKRGV DFURVV D UDQJH RI GDWD VHWWLQJV DQG VKRZQ WKDW WKHVH PHWKRGV FDQ DFFXUDWHO\ SURMHFW WUHDWPHQW HIIHFWV IURP RQH VWXG\ SRSXODWLRQ WR D VHFRQG 7UDQVSRUWDELOLW\ PHWKRGV WKHUHIRUH SURYLGH D VWDWLVWLFDO WRRO WR DGGUHVV WKH HYLGHQFH JDS EHWZHHQ 5&7V DQG UHDOZRUOG FDUH 7KH SURSRVDO IRFXVHV RQ ILYH UHFHQW 5&7V LQ LQGLYLGXDOV ZLWK 7' *5$'( &$19$6 (03$5(* 287&20( /($'(5 DQG 6867$,1 *5$'( FRPSDUHG IRXU PHGLFDWLRQV DV VHFRQGOLQH WUHDWPHQW IRU 7' LQ LQGLYLGXDOV ZLWK LQDGHTXDWH JOXFRVH FRQWURO RQ PHWIRUPLQ DORQH ± D YHU\ FRPPRQ FOLQLFDO VFHQDULR LQ WKH 9$ &$19$6 DQG (03$5(* 287&20( H[DPLQHG FDUGLRYDVFXODU DQG UHQDO RXWFRPHV DVVRFLDWHG ZLWK WKH 6*/7L FDQDJOLIOR]LQ DQG HPSDJOLIOR]LQ UHVSHFWLYHO\ WKH ODWWHU EHLQJ WKH PRVW FRPPRQO\ SUHVFULEHG 6*/7L LQ WKH 9$ /($'(5 DQG 6867$,1 H[DPLQHG FDUGLRYDVFXODU DQG UHQDO RXWFRPHV DVVRFLDWHG ZLWK WKH */35$ OLUDJOXWLGH DQG VHPDJOXWLGH UHVSHFWLYHO\ ± WKH WZR PRVW IUHTXHQWO\ XVHG */35$ LQ WKH 9$ $LP ZLOO SURYLGH HIIHFW HVWLPDWHV RI */35$ 6*/7L DQG DGGLWLRQDO JOXFRVHORZHULQJ PHGLFDWLRQV RQ JO\FHPLF DQG FDUGLRUHQDO RXWFRPHV EDVHG RQ WKHVH ILYH 5&7V WUDQVSRUWHG WR all trial-eligible Veterans with T2D ,Q $LP WKH WDUJHW SRSXODWLRQV DUH QDUURZHG WR VXEJURXSV RI 9HWHUDQV EDVHG RQ DJH DQG HOHYDWHG ULVN RI FDUGLRUHQDO FRPSOLFDWLRQV WR JDLQ LQVLJKW LQWR potential benefits of prioritizing specific subgroups of Veterans for treatment with GLP1RA and SGLT2i $LP HVWLPDWHV WKH QXPEHU RI FDUGLRYDVFXODU HYHQWV SUHYHQWHG DQG 9$ V\VWHP ZLGH FRVWV XQGHU GLIIHUHQW WUHDWPHQW SROLFLHV ± WUHDW DOO HOLJLEOH 9HWHUDQV YHUVXV SULRULWL]LQJ VSHFLILF VXEJURXSV 7KLV VWXG\ LV LQQRYDWLYH LQ LWV DSSOLFDWLRQ RI HPHUJLQJ ELRVWDWLVWLFDO WRROV ± WUDQVSRUWDELOLW\ PHWKRGV ± WR DGGUHVV D JDS LQ DFWLRQDEOH HYLGHQFH EHWZHHQ LQIOXHQWLDO 5&7V ZLWK IHZ 9HWHUDQ SDUWLFLSDQWV DQG FRPSDUDWLYH HIIHFWLYHQHVV UHVHDUFK VWXGLHV LQ 9HWHUDQV *LYHQ WKH SRWHQWLDOO\ EURDGHU DSSOLFDWLRQV RI WUDQVSRUWDELOLW\ PHWKRGV WKH VWXG\ LV SRLVHG IRU ODVWLQJ LPSDFW E\ SURYLGLQJ DQ DQDO\WLF URDGPDS DQG DFFRPSDQ\LQJ VWDWLVWLFDO FRGH DQG SLSHOLQH WR IDFLOLWDWH WKH XVH RI WKHVH PHWKRGV LQ WKH 9$ LQ RWKHU GLVHDVHGUXJ FRQWH[WV LQ WKH IXWXUH
View original record on NIH RePORTER →